Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...

February 6, 2025 • It's Black History Month and the Up First newsletter wants to highlight local history makers. Do you know anyone who has made a difference and should be celebrated this month ...

NPR's Up First is the news you need to start your day. The three biggest stories of the day, with reporting and analysis from NPR News — in 10 minutes. Available weekdays at 6:30 a.m. ET, with ...

Last week's survey by the British Potato Council revealed that we prefer mash to chips. So is this good news for our health? Nutritionally speaking, both mash and chips are good sources of energy ...

Found the Volkswagen Up of your dreams? Now you want to know all about it! With the help of Parkers, you can find out all of the key specs about the Volkswagen Up from fuel efficiency in MPG and top ...